Criteria
Hypochondriasis initially appeared in DSM-II as one of the neuroses. In DSM-III, it was moved to the somatoform disorders, and diagnostic criteria were provided. In a revision of the classification (DSM-III-R), a duration of 6 months was added, and patients with delusional beliefs were excluded. The DSM-IV criteria are shown in
Table 5.2.5.2. They exclude patients whose symptoms are better explained by other anxiety, depressive, or somatoform disorders.
(1) Also, in DSM-IV, specific phobia of illness is separated from hypochondriasis. The illness phobic is said to fear contracting an illness whereas the hypochondriac fears disease already present.
The ICD-10 criteria for hypochondriacal disorder differ from those in DSM-IV. They require a persistent belief about having one or more specifically named serious physical diseases.
(6) In addition, they include body dysmorphic disorder. With respect to illness behaviour, the ICD-10 criteria state that hypochondriacal concerns cause persons to seek medical investigation or treatment. They also state that patients may accept reassurance in the short-term, but that in the long run they are not likely to respond.
The somatoform disorders category to which hypochondriasis belongs is controversial, and many question its inclusion in the classification.
(7) They see these disorders as ill-defined, of questionable validity and based more on illness behaviour than on distinctive features. They also view them as creations of Western biomedicine that serve to devalue patients who challenge the theoretical model upon which it is based.
(8) According to that model, illness is a response to disease, and the person who is ill without disease, e.g. hypochondriasis, is marginalized.
Were the somatoform disorders to be eliminated, some have proposed moving hypochondriasis to the anxiety disorders (health anxiety) or to a proposed grouping, the obsessive-compulsive spectrum disorders.
Validity
Evidence for the validity and utility of the diagnosis of hypochondriasis remains limited. In studies aimed at demonstrating validity, Barsky
et al.
(9) showed that distinguishing characteristics of the disorder aggregated in some medical outpatients but were less common in others. The same patients had other features of hypochondriasis indicating external validity. Using a structured interview for hypochondriasis, these investigators and others
(10,11) observed a positive correlation between interview and physician ratings (concurrent validity). Hypochondriacal patients also had more ancillary features of hypochondriasis than did control patients (external validity). Also, other clinical characteristics distinguished interview positive from interview negative patients, indicating discriminate validity. Follow-up studies have shown a degree of diagnostic stability suggesting predictive validity.
(12,13)
Measures
A variety of measures have been developed to screen for hypochondriasis and assess the severity of hypochondriacal concerns.
(14) These are shown in
Table 5.2.5.3. The Whiteley Index, a self-report instrument based on the observed characteristics of hypochondriacal psychiatric patients, is one of the most widely used.
(15) It consists of 14 yes versus no items, but recent work suggests that a 7-item version is satisfactory for screening. The Illness Attitude Scales is a 27-item measure of psychopathology associated with hypochondriasis.
(16) A principal components’ analysis yielded two factors, one measuring health anxiety and the other illness behaviour. The health anxiety subscale has been used to distinguish hypochondriacal from non-hypochondriacal patients.
Recently, self-assessment measures have been developed to assess the various dimensions of health anxiety and hypochondriasis. The Health Anxiety Inventory contains 47 items covering a range of hypochondriacal features.
(17) An advantage of this scale is that it distinguishes patients with high health anxiety from those with physical illness.
The Structured Clinical Interview for DSM-IV (SCID) and the Composite International Diagnostic Interview (CIDI) are comprehensive diagnostic interviews that contain somatoform disorder modules. The CIDI has been used in epidemiologic surveys. Its stem question for hypochondriasis is, ‘In the past 12 months, have you had a period of 6 months or more when most of the time you worried about having a serious physical illness or deformity?’
Based on the SCID, Barsky
et al.
(10) developed a structured interview that focuses exclusively on hypochondriasis. It begins with a series of probe questions that, if answered affirmatively, trigger the remaining interview. It is suitable for confirming the diagnosis in a screened population.
Diagnostic assessment remains less than satisfactory because the threshold for caseness has not been established, medical and psychiatric comorbidity make diagnostic decision-making difficult, and independent medical evaluation is rarely part of the process.